Lomustine
Astrocytoma of Brain
Jasper GerritsenSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Astrocytoma of Brain cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
coq10 Seema Nagpal | Phase 1 | CC |
Intranasal Modified Temozolomide Center Trials & Treatment Europe | Phase 1 | CC |
Triapine National Cancer Institute (NCI) | Phase 1 | NR |
Same molecule, other indications
Lomustine is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →